COCP Projected Dividend Yield
Com Par $ (New)/Cocrystal Pharma Inc ( NASDAQ : COCP )Cocrystal Pharma, Inc. is a clinical-stage biotechnology company. Co. is engaged in discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses (HCV). It is developing small molecule antiviral therapeutics that inhibit the essential viral replication function of RNA viruses causing acute and chronic viral diseases. It has several candidates under development for the treatment of influenza infection. CC-42344 is a novel PB2 inhibitor, which is a preclinical lead for the treatment of pandemic and seasonal influenza A. 21 YEAR PERFORMANCE RESULTS |
COCP Dividend History Detail COCP Dividend News COCP Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |